Cascade Chemistry, a pharmaceutical CDMO, began construction of new facilities to increase capacity to manufacture APIs under cGMP.   The new facilities, expected to be operational in 1Q22, will increase floor space almost three-fold and significantly add to its cGMP manufacturing capacity and scale. The $14 million expansion also includes 2,200 sq.-ft. of new analytical labs, a robust quality system and additional office space.

   The 28,000-sq.-ft. building currently under construction wi...